恆騰網絡(00136.HK)附屬與騰訊科技訂立合作協議
格隆匯 4 月 20日丨恆騰網絡(00136.HK)發佈公吿,公司的附屬公司北京曉明(南瓜電影運營主體)於2021年4月19日與騰訊科技訂立合作協議。根據合作協議,南瓜電影將與騰訊視頻深度合作,屆時南瓜電影將獲得騰訊獨家版權的海量影視作品的授權,供會員觀賞。
訂立合作協議將有助集團充分整合和利用平台資源,未來集團將依託公司股東在整個產業鏈生態及相關數據領域的優勢和實力,進一步提升和完善產業鏈上下游業務及線上線下渠道,打造數字科技賦能、世界領先的流媒體平台。此外,合作協議亦可讓集團為南瓜電影會員提供更多不同種類的優質影視作品,提高南瓜電影的知名度,從而提升集團在影視播放行業的市場影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.